Overview

Cell Based Assay Market is poised to register a CAGR of 8.1% during the forecast period 2022 to 2028.

Depending in the end-user, the market is fragmented into academic and government institutes, contract research organizations (CRO) and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment currently holds the largest market share and this trend will continue over the forecast period. However, the CRO segment is predicted to grow with a high CAGR value during the forecast period. This growth can be attributed to the increased outsourcing of drug discovery activities by pharmaceutical firms to CRO.

The drug discovery segment is predicted to boost market growth over the forecast period. This growth is due to the increase in investments on research and development by pharmaceutical companies. Furthermore, the increasing prevalence of diabetes and cardiovascular diseases is spurring market growth. Moreover, a rapid rise in the drugs used for treating chronic diseases across the world has boosted the market growth.

North America currently dominates the market. However, the Asia Pacific region is predicted to grow at a high CAGR value over the forecast period. The growth in this region is largely due to advancements in infrastructure development and massive investments in research and development by governments of emerging economies.

key market players are Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Ge Healthcare, Merck KGaA, Lonza Group Ltd., Perkinelmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technology, Inc., Promega Corporation, Cisbio, Cell Biolabs, Inc.

Cell Based Assay Market Segmentation:

By Product & Services

• Consumables
• Reagents
• Assay Kits
o Reporter Gene Assays
o Second Messenger Assays
o Cell Growth Assays
o Cell Death Assays
o Other Assay Kits
• Probes & Labels
• Microplates
• Cell Lines
o Immortalized Cell Lines
o Primary Cell Lines
o Stem Cell Lines
• Instruments
• Services

By Application

• Drug Discovery
• Toxicity Studies
o Pharmacokinetic Studies
o Pharmacodynamic Studies
• Basic Research
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Government Institutes
• Contract Research Organizations

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the cell-based assay market by product & services, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and rest of the world
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies